FCH
SRNE

Freestone Capital Holdings’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Freestone Capital Holdings’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,000
Closed -$6.83K – 1226
2020
Q4 		$6.83K Hold
1,000
– – ﹤0.01% 927
2020
Q3 		$11.2K Buy
+1,000
New +$11.2K ﹤0.01% 725